Abigail Lennox Biography and Net Worth

Executive Vice President & Chief Scientific Officer of Perrigo

Abbie Lennox was named Executive Vice President and Chief Scientific Officer in January 2025. Ms. Lennox joins Perrigo from Bayer where she served as Executive Board Member and Chief Trust and Science Officer, responsible for leading the regulatory, medical affairs, safety, and quality teams. She led multiple innovation launches – both product and claim-based – across product categories in cardio, digestive health, allergy, cough, cold, pain, dermatology, women's health, VMS, and Rx to OTC switches in the U.S. and the rest of the world. Specifically, Ms. Lennox provided scientific leadership for the U.S. Rx-to-OTC switch for Astepro®, emphasizing consumer-centric claims supported by robust medical insights. She also led the introduction of Rennie Gum, the first European OTC chewing gum for digestive health, navigating rigorous clinical and registration requirements while prioritizing consumer experience. Prior to her time at Bayer, she served in regulatory affairs leadership roles with Reckitt Benckiser, where she advanced the company’s regulatory approach to pipeline delivery across multiple health and wellness brands. Ms. Lennox holds a First Class BSc (Honors) degree in Biomedical Science and Chemistry from De Montfort University.

What is Abigail Lennox's net worth?: The estimated net worth of Abigail Lennox is at least $16.90 thousand as of September 8th, 2025. Ms. Lennox owns 1,255 shares of Perrigo stock worth more than $16,899 as of December 4th. This net worth estimate does not reflect any other assets that Ms. Lennox may own. Learn More about Abigail Lennox's net worth.
How do I contact Abigail Lennox?: The corporate mailing address for Ms. Lennox and other Perrigo executives is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. Perrigo can also be reached via phone at (531) 709-4000 and via email at [email protected]. Learn More on Abigail Lennox's contact information.
Has Abigail Lennox been buying or selling shares of Perrigo?: Abigail Lennox has not been actively trading shares of Perrigo in the last ninety days. Most recently, on Monday, September 8th, Abigail Lennox bought 1,255 shares of Perrigo stock. The stock was acquired at an average cost of $22.41 per share, with a total value of $28,124.55. Following the completion of the transaction, the executive vice president now directly owns 1,255 shares of the company's stock, valued at $28,124.55. Learn More on Abigail Lennox's trading history.
Who are Perrigo's active insiders?: Perrigo's insider roster includes Bradley Alford (Director), Svend Andersen (EVP), Eduardo Bezerra (CFO), Rolf Classon (Director), James Dillard, III (EVP), Thomas Farrington (EVP), Alison Ives (EVP), Ronald Janish (EVP), Murray Kessler (CEO), Todd Kingma (VP), Abigail Lennox (Executive Vice President & Chief Scientific Officer), Patrick Lockwood-Taylor (President, CEO & Director), Geoffrey Parker (Director), Grainne Quinn (EVP), Theodore Samuels, II (Director), Raymond Silcock (CFO), Richard Sorota (EVP), and Robert Willis (EVP). Learn More on Perrigo's active insiders.
Are insiders buying or selling shares of Perrigo?: During the last twelve months, Perrigo insiders bought shares 5 times. They purchased a total of 17,618 shares worth more than $339,049.10. During the last twelve months, insiders at the sold shares 2 times. They sold a total of 25,398 shares worth more than $711,527.46. The most recent insider tranaction occured on November, 12th when Director Geoffrey M Parker bought 7,500 shares worth more than $106,350.00. Insiders at Perrigo own 0.7% of the company. Learn More about insider trades at Perrigo.
Information on this page was last updated on 11/12/2025.

Abigail Lennox Insider Trading History at Perrigo

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/8/2025	Buy	1,255	$22.41	$28,124.55	1,255

Abigail Lennox Buying and Selling Activity at Perrigo

Perrigo Company Overview

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Today's Range

Now: $13.47

$13.34

$14.07

50 Day Range

MA: $18.08

$12.25

$22.52

2 Week Range

Now: $13.47

$12.17

$30.93

Volume

2,961,132 shs

Average Volume

4,074,137 shs

Market Capitalization

$1.85 billion

P/E Ratio

N/A

Dividend Yield

8.31%

Beta

0.39